GlaxoSmithKline (GSK) launched its new campaign Target the Future to address the current challenges patients with multiple myeloma and healthcare providers face. This campaign will provide education, identify key challenges the multiple myeloma community faces, and facilitate solutions to create a better future for patients, caregivers, and loved ones.
A component of this campaign is the Target the Future Think Tank Challenge, which is now accepting idea submissions. The winner will receive a $100,000 grant to bring their idea to life.
For more information on this campaign and how you can get involved, read GSK's announcement.
Posted 12/16/2021
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
